Total Payments
$500,463
2024 Payments
$83,111
Companies
35
Transactions
893
Medicare Patients
2,886
Medicare Billing
$346,448
Payment Breakdown by Category
Other$416,092 (83.1%)
Travel$33,161 (6.6%)
Consulting$27,208 (5.4%)
Food & Beverage$23,958 (4.8%)
Education$43.37 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $310,297 | 176 | 62.0% |
| Honoraria | $105,795 | 43 | 21.1% |
| Travel and Lodging | $33,161 | 159 | 6.6% |
| Consulting Fee | $27,208 | 19 | 5.4% |
| Food and Beverage | $23,958 | 491 | 4.8% |
| Education | $43.37 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SK Life Science, Inc. | $88,961 | 115 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $71,491 | 85 | $0 (2021) |
| JAZZ PHARMACEUTICALS INC. | $68,467 | 60 | $0 (2024) |
| EISAI INC. | $66,010 | 101 | $0 (2022) |
| UCB, Inc. | $64,958 | 148 | $0 (2024) |
| Neurelis, Inc. | $49,928 | 71 | $0 (2024) |
| Greenwich Biosciences, Inc. | $31,294 | 41 | $0 (2021) |
| Adamas Pharmaceuticals, Inc. | $22,842 | 7 | $0 (2021) |
| MDD US Operations, LLC | $19,758 | 21 | $0 (2023) |
| CATALYST PHARMACEUTICALS, INC. | $6,447 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $83,111 | 178 | JAZZ PHARMACEUTICALS INC. ($34,258) |
| 2023 | $87,301 | 176 | Neurelis, Inc. ($28,828) |
| 2022 | $70,719 | 139 | SK Life Science, Inc. ($33,069) |
| 2021 | $67,840 | 95 | Adamas Pharmaceuticals, Inc. ($22,720) |
| 2020 | $38,395 | 70 | SK Life Science, Inc. ($10,998) |
| 2019 | $55,420 | 78 | EISAI INC. ($26,825) |
| 2018 | $29,166 | 51 | Sunovion Pharmaceuticals Inc. ($14,647) |
| 2017 | $68,510 | 106 | Sunovion Pharmaceuticals Inc. ($32,145) |
All Payment Transactions
893 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/16/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,940.00 | General |
| Category: NEUROLOGY | ||||||
| 12/16/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Travel and Lodging | In-kind items and services | $253.26 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2024 | Neurelis, Inc. | VALTOCO (Drug) | Travel and Lodging | Cash or cash equivalent | $42.21 | General |
| Category: EPILEPSY | ||||||
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $7.36 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/11/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: NEUROLOGY | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Neurology | ||||||
| 12/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $10.06 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/04/2024 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $86.29 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 12/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | Neurelis, Inc. | VALTOCO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,608.00 | General |
| Category: EPILEPSY | ||||||
| 11/26/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $6.51 | General |
| Category: Neurology | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.77 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/20/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Honoraria | Cash or cash equivalent | $3,500.00 | General |
| Category: Neurology | ||||||
| 11/20/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Travel and Lodging | In-kind items and services | $613.96 | General |
| Category: Neurology | ||||||
| 11/20/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Travel and Lodging | In-kind items and services | $284.03 | General |
| Category: Neurology | ||||||
| 11/20/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Travel and Lodging | Cash or cash equivalent | $148.57 | General |
| Category: Neurology | ||||||
| 11/20/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $119.12 | General |
| Category: Neurology | ||||||
| 11/20/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | Cash or cash equivalent | $48.48 | General |
| Category: Neurology | ||||||
| 11/14/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $124.94 | General |
| Category: EPILEPSY | ||||||
| 11/14/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.02 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/13/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Honoraria | Cash or cash equivalent | $2,500.00 | General |
| Category: Neurology | ||||||
| 11/13/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Travel and Lodging | Cash or cash equivalent | $125.96 | General |
| Category: Neurology | ||||||
| 11/13/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $81.35 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 678 | 1,085 | $275,962 | $81,617 |
| 2022 | 16 | 736 | 1,184 | $270,191 | $94,606 |
| 2021 | 18 | 761 | 1,161 | $264,375 | $97,882 |
| 2020 | 15 | 711 | 1,035 | $191,560 | $72,343 |
Total Patients
2,886
Total Services
4,465
Medicare Billing
$346,448
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 57 | 187 | $79,662 | $28,718 | 36.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 190 | 250 | $47,634 | $16,139 | 33.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 71 | 144 | $23,040 | $8,644 | 37.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 137 | 142 | $51,830 | $5,956 | 11.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 42 | 42 | $18,690 | $5,383 | 28.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 29 | 29 | $9,210 | $2,893 | 31.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 42 | 69 | $7,590 | $2,621 | 34.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 26 | 26 | $7,800 | $2,524 | 32.4% |
| 95984 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | Facility | 2023 | 18 | 77 | $12,204 | $2,405 | 19.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 13 | 19 | $6,035 | $1,872 | 31.0% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Facility | 2023 | 18 | 51 | $4,926 | $1,854 | 37.6% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2023 | 17 | 17 | $4,760 | $1,737 | 36.5% |
| 95971 | Electronic analysis of implanted neurostimulator generator with simple spinal cord or peripheral nerve stimulator programming | Facility | 2023 | 18 | 32 | $2,580 | $871.49 | 33.8% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 57 | 219 | $93,294 | $35,323 | 37.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 202 | 265 | $35,395 | $17,231 | 48.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 91 | 187 | $29,920 | $10,329 | 34.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 54 | 58 | $25,810 | $8,327 | 32.3% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 113 | 121 | $44,165 | $5,124 | 11.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 57 | 57 | $10,070 | $5,096 | 50.6% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2022 | 19 | 20 | $5,600 | $2,118 | 37.8% |
| 95984 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | Facility | 2022 | 13 | 61 | $3,050 | $2,047 | 67.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $4,500 | $1,507 | 33.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 37 | 46 | $5,060 | $1,388 | 27.4% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Facility | 2022 | 13 | 35 | $1,995 | $1,305 | 65.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 11 | 12 | $2,480 | $1,227 | 49.5% |
About Dr. Daniel Mattson, MD
Dr. Daniel Mattson, MD is a Neurology healthcare provider based in Bridgeton, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1447237870.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Mattson, MD has received a total of $500,463 in payments from pharmaceutical and medical device companies, with $83,111 received in 2024. These payments were reported across 893 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($310,297).
As a Medicare-enrolled provider, Mattson has provided services to 2,886 Medicare beneficiaries, totaling 4,465 services with total Medicare billing of $346,448. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Bridgeton, MO
- Active Since 12/28/2005
- Last Updated 10/23/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1447237870
Products in Payments
- XCOPRI (Drug) $76,425
- APTIOM (Drug) $71,475
- Fycompa (Drug) $65,884
- EPIDIOLEX (Drug) $63,058
- VALTOCO (Drug) $49,928
- Briviact (Drug) $46,493
- GOCOVRI (Drug) $42,099
- Epidiolex (Drug) $31,294
- Cenobamate (Drug) $10,770
- Nayzilam (Drug) $8,118
- FYCOMPA (Drug) $6,447
- XYWAV (Drug) $5,409
- Fintepla (Drug) $4,889
- VNS Therapy (Device) $3,578
- BOTOX (Biological) $1,118
- UBRELVY (Drug) $758.39
- Vimpat (Drug) $750.00
- PERCEPT PC BRAINSENSE (Device) $653.92
- APOKYN (Drug) $500.00
- ACTIVA (Device) $490.59
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Bridgeton
Dr. Siddharth Kaul, Md, MD
Neurology — Payments: $552,004
Neurology $552,004
Dr. Seth Hepner, Md, MD
Neurology — Payments: $251,257
Neurology $251,257
Dr. Xinrong Lu, M.d, M.D
Neurology — Payments: $22,610
Neurology $22,610
Dr. Amer Alshekhlee, Md, MD
Neurology — Payments: $14,239
Neurology $14,239
Dr. Chizoba Ezepue, Md, MD
Neurology — Payments: $5,505
Neurology $5,505
Dr. Robert Margolis, M.d, M.D
Neurology — Payments: $3,305
Neurology $3,305